Literature DB >> 12205219

The safety of homeopathic products.

Peter Fisher, Flavio Dantas, Hagen Rampes.   

Abstract

Mesh：

Year:  2002        PMID： 12205219      PMCID： PMC1280007          DOI： 10.1258/jrsm.95.9.474-b

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  2 in total

Review 1.  Do homeopathic medicines provoke adverse effects? A systematic review.

Authors:  F Dantas; H Rampes
Journal:  Br Homeopath J       Date:  2000-07

2.  Safety of homeopathic products.

Authors:  Brian J Kirby
Journal:  J R Soc Med       Date:  2002-05       Impact factor: 18.000
  2 in total
  5 in total

1.  Immunology and homeopathy. 4. Clinical studies-part 2.

Authors:  Paolo Bellavite; Riccardo Ortolani; Francesco Pontarollo; Valeria Piasere; Giovanni Benato; Anita Conforti
Journal:  Evid Based Complement Alternat Med       Date:  2006-07-31       Impact factor: 2.629

2.  Anthroposophic Medicine: A Short Monograph and Narrative Review-Foundations, Essential Characteristics, Scientific Basis, Safety, Effectiveness and Misconceptions.

Authors:  Ricardo R Bartelme
Journal:  Glob Adv Health Med       Date:  2020-12-29

3.  The Red flag! risk assessment among medical homeopaths in Norway: a qualitative study.

Authors:  Trine Stub; Terje Alraek; Anita Salamonsen
Journal:  BMC Complement Altern Med       Date:  2012-09-11       Impact factor: 3.659

Review 4.  Mapping the risk perception and communication gap between different professions of healthcare providers in cancer care: a cross-sectional protocol.

Authors:  Trine Stub; Frauke Musial; Sara A Quandt; Thomas A Arcury; Anita Salamonsen; Agnete Kristoffersen; Gro Berntsen
Journal:  BMJ Open       Date:  2015-09-03       Impact factor: 2.692

5.  Attitudes and knowledge about direct and indirect risks among conventional and complementary health care providers in cancer care.

Authors:  Trine Stub; Sara A Quandt; Thomas A Arcury; Joanne C Sandberg; Agnete E Kristoffersen
Journal:  BMC Complement Altern Med       Date:  2018-01-31       Impact factor: 3.659
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.